Details of the Drug
General Information of Drug (ID: DMAKZ43)
| Drug Name |
2,8-Dimethyl-1-oxa-8-aza-spiro[4.5]decan-3-one
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Synonyms |
2,8-dimethyl-1-oxa-8-azaspiro[4.5]decan-3-one; CHEMBL40121; 123319-03-9; ARL-14995; 2,8-Dimethyl-1-oxa-8-aza-spiro[4.5]decan-3-one; SCHEMBL1326512; 1-Oxa-8-azaspiro[4.5]decan-3-one, 2,8-dimethyl-; MolPort-039-242-339; OODDNJQTVFMGCF-UHFFFAOYSA-N; BDBM50034651; AKOS033633463; 2,8-dimethyl-1-oxa-8-azaspiro[4,5]decan-3-one; L010200; 2,8-dimethyl-1-oxa-8-azaspiro[4.5]-decan-3-one; 2,8-dimethyl-1-oxa-8-azaspiro[4,5]-decan-3-one
|
||||||||||||||||||
| Indication |
|
||||||||||||||||||
| Drug Type |
Small molecular drug
|
||||||||||||||||||
| Structure |
![]() |
||||||||||||||||||
| 3D MOL | 2D MOL | ||||||||||||||||||
| #Ro5 Violations (Lipinski): 0 | Molecular Weight (mw) | 183.25 | |||||||||||||||||
| Logarithm of the Partition Coefficient (xlogp) | 0.4 | ||||||||||||||||||
| Rotatable Bond Count (rotbonds) | 0 | ||||||||||||||||||
| Hydrogen Bond Donor Count (hbonddonor) | 0 | ||||||||||||||||||
| Hydrogen Bond Acceptor Count (hbondacc) | 3 | ||||||||||||||||||
| Chemical Identifiers |
|
||||||||||||||||||
| Cross-matching ID | |||||||||||||||||||
Molecular Interaction Atlas of This Drug
![]() Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||||||||||||||||
Molecular Expression Atlas of This Drug
| The Studied Disease | Discovery agent | |||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ICD Disease Classification | N.A. | |||||||||||||||||||||||
|
||||||||||||||||||||||||
| Molecular Expression Atlas (MEA) | ||||||||||||||||||||||||


